Evonile Pharma Limited
The day and the year
- Open
- ₹1,589.60
- Day range
- ₹1,501.40 – ₹1,594.80
- Previous close
- ₹1,589.60
- Volume
- 47,355
- Delivery
- 54.8%
- Turnover
- ₹7.27 Cr
Trading pattern, 20 sessions
- Average delivery
- 59.9%
- Average volume
- 78,628
- Today vs average
- 0.6×
Delivery is the share of traded quantity settled by delivery rather than squared off the same day.
Price over the last year
Financials
Financial statements
| Line item | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 85 | 81 | 92 | 87 | 93 | 84 | 88 | 90 | 86 | 91 | 104 | 56 |
| YoY Sales growth | — | — | — | — | — | — | -5 | — | -8 | — | — | -38 |
| Expenses | 65 | 70 | 68 | 69 | 67 | 60 | 60 | 66 | 64 | 70 | 69 | 88 |
| Operating Profit | 20 | 11 | 24 | 18 | 26 | 24 | 27 | 24 | 22 | 21 | 35 | -32 |
| OPM % | 23% | 14% | 26% | 21% | 28% | 29% | 31% | 26% | 26% | 23% | 34% | -57% |
| Other Income | 22 | 10 | 10 | 10 | 11 | 11 | 11 | 9 | 9 | 10 | 9 | -61 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 5 |
| Depreciation | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 4 |
| Profit before tax | 41 | 21 | 34 | 28 | 35 | 34 | 37 | 33 | 30 | 30 | 43 | -101 |
| Tax % | 36% | 31% | 24% | 26% | 28% | 14% | 26% | 26% | 46% | 16% | 25% | -23% |
| Net Profit | 27 | 15 | 26 | 20 | 25 | 29 | 28 | 24 | 16 | 25 | 32 | -78 |
| EPS in Rs | ₹9.07 | ₹5.01 | ₹8.78 | ₹6.97 | ₹8.69 | ₹10.00 | ₹9.43 | ₹8.27 | ₹5.49 | ₹8.62 | ₹10.99 | ₹-26.46 |
From company filings, updated 13 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.
Listing details
- Listed on NSE
- 20 Apr 2026
- ISIN
- INE234A01025
- Face value
- ₹5
- Board and series
- Main board · EQ
Trade EVONILE through Rajat Finance
Buy and sell Evonile Pharma Limited on NSE from one Demat account, with an office in Panipat to call.
Financials from company filings via screener.in; research profiles are kept for the 750 stocks in the screener.
End-of-day figures from NSE's bhavcopy with delivery data and NSE's list of listed securities. Market data, not investment advice.